title: Is there a risk of sensitizing islet recipients to HLA?
authors.affiliation: University of Minnesota Medical School, Minneapolis Medical Research Foundation.
authors.forename: C T
authors.initials: CT
authors.lastname: Lum
authors.forename: H J
authors.initials: HJ
authors.lastname: Noreen
authors.forename: P
authors.initials: P
authors.lastname: Gores
authors.forename: J
authors.initials: J
authors.lastname: Dolbec
authors.forename: D E
authors.initials: DE
authors.lastname: Sutherland
authors.forename: M
authors.initials: M
authors.lastname: Segall
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy / Q000379:methods; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D012189:Retrospective Studies; D014184:Transplantation, Homologous
chemical_list: D000888:Antibodies, Anti-Idiotypic; D006680:HLA Antigens